Global

Philips IntelliVue Active Display, AD75 and AD85

Philips IntelliVue Active Display, AD75 and AD85
Asset published on June 2, 2020
Select your preferred file

Description

Philips IntelliVue Active Displays receive FDA Emergency Use Authorization for use during COVID-19, offering advanced clinical decision support and meaningful patient insights.

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.